122 related articles for article (PubMed ID: 38185216)
1. [18F]-fluorodeoxyglucose PET-CT in systemic amyloidosis with cardiac involvement.
García-Olea Jurado A; Fernández de la Prieta I; Ruiz Gómez L
Rev Esp Cardiol (Engl Ed); 2024 Jan; ():. PubMed ID: 38185216
[No Abstract] [Full Text] [Related]
2. Utility of 18F-FDG PET(/CT) in patients with systemic and localized amyloidosis.
Glaudemans AW; Slart RH; Noordzij W; Dierckx RA; Hazenberg BP
Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1095-101. PubMed ID: 23474745
[TBL] [Abstract][Full Text] [Related]
3. Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body
Ehman EC; El-Sady MS; Kijewski MF; Khor YM; Jacob S; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Falk RH; Hyun H; Dorbala S
J Nucl Med; 2019 Sep; 60(9):1234-1239. PubMed ID: 30954943
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary amyloidosis in a patient with Langerhans cell histiocytosis: diagnostic dilemma on 18F-FDG PET/CT.
Mukherjee A; Dhull VS; Sharma P; Parida GK; Jain S; Pal L; Kumar R
Clin Nucl Med; 2014 Apr; 39(4):e263-4. PubMed ID: 24097004
[TBL] [Abstract][Full Text] [Related]
5. [18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions.
Genovesi D; Vergaro G; Giorgetti A; Marzullo P; Scipioni M; Santarelli MF; Pucci A; Buda G; Volpi E; Emdin M
JACC Cardiovasc Imaging; 2021 Jan; 14(1):246-255. PubMed ID: 32771577
[TBL] [Abstract][Full Text] [Related]
6. 18F-Florbetapir and 18F-FDG PET/CT in Systemic Immunoglobulin Light Chain Amyloidosis Involving the Peripheral Nerves.
Broski SM; Spinner RJ; Howe BM; Dispenzieri A; Johnson GB
Clin Nucl Med; 2016 Feb; 41(2):e115-7. PubMed ID: 26284768
[TBL] [Abstract][Full Text] [Related]
7.
Young KA; Lyle M; Rosenbaum AN; Chang IC; Lin G; Bois MC; Ezzeddine OFA; Jouni H; Chareonthaitawee P; Kapa S; Grogan M; Cooper LT; Blauwet L; Bois JP
J Nucl Cardiol; 2023 Apr; 30(2):726-735. PubMed ID: 35084701
[No Abstract] [Full Text] [Related]
8. Reappraisal of [18F]FDG-PET/CT for diagnosis and management of cardiac implantable electronic device infections.
Hernández-Meneses M; Perissinotti A; Páez-Martínez S; Llopis J; Dahl A; Sandoval E; Falces C; Ambrosioni J; Vidal B; Marco F; Cuervo G; Moreno A; Bosch J; Tolosana JM; Fuster D; Miró JM;
Rev Esp Cardiol (Engl Ed); 2023 Dec; 76(12):970-979. PubMed ID: 37028797
[TBL] [Abstract][Full Text] [Related]
9. Amyloid Arthropathy and Pseudomyopathy Associated With Multiple Myeloma Detected by 18F-Florapronol Amyloid PET/CT.
Seo M; Lee YJ; Kim M; Kang BS; Park SH
Clin Nucl Med; 2022 Apr; 47(4):e375-e376. PubMed ID: 35119394
[TBL] [Abstract][Full Text] [Related]
10. [The role of PET-CT in decision making on the treatment of localized nodular form of pulmonary AL-amyloidosis].
Adam Z; Elleder M; Moulis M; Tichý M; Cervinková I; Rehák Z; Koukalová R; Fojtík Z; Hanke I; Pour L; Krejčí M; Zahradová L; Szturz P; Hájek R; Král Z; Mayer J
Vnitr Lek; 2012 Mar; 58(3):241-52. PubMed ID: 22486293
[TBL] [Abstract][Full Text] [Related]
11. 18F-fluorodeoxyglucose positron emission tomography might be useful for diagnosis of hepatic amyloidosis.
Tawada A; Kanda T; Oide T; Tsuyuguchi T; Imazeki F; Nakatani Y; Yokosuka O
Int Med Case Rep J; 2014; 7():103-9. PubMed ID: 25018655
[TBL] [Abstract][Full Text] [Related]
12. Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT?
Gagliardi C; Tabacchi E; Bonfiglioli R; Diodato S; Nanni C; Guidalotti P; Lorenzini M; Lodi F; Milandri A; Rapezzi C; Fanti S
J Nucl Cardiol; 2017 Apr; 24(2):746-749. PubMed ID: 26976144
[TBL] [Abstract][Full Text] [Related]
13. Imaging Findings and Literature Review of (18)F-FDG PET/CT in Primary Systemic AL Amyloidosis.
Lee JH; Lee GY; Kim SJ; Kim KH; Jeon ES; Lee KH; Kim BT; Choi JY
Nucl Med Mol Imaging; 2015 Sep; 49(3):182-90. PubMed ID: 26279691
[TBL] [Abstract][Full Text] [Related]
14. Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma.
Ömür Ö; Baran Y; Oral A; Ceylan Y
Diagn Interv Radiol; 2014; 20(2):185-92. PubMed ID: 24412817
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of 18F-FDG-PET/CT in the extra cardiac work-up of patients with infective endocarditis.
Asmar A; Ozcan C; Diederichsen AC; Thomassen A; Gill S
Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1013-9. PubMed ID: 24711514
[TBL] [Abstract][Full Text] [Related]
16. [18F]-NaF PET/CT imaging in cardiac amyloidosis.
Van Der Gucht A; Galat A; Rosso J; Guellich A; Garot J; Bodez D; Plante-Bordeneuve V; Hittinger L; Dubois-Randé JL; Evangelista E; Sasanelli M; Chalaye J; Meignan M; Itti E; Damy T
J Nucl Cardiol; 2016 Aug; 23(4):846-9. PubMed ID: 26403145
[TBL] [Abstract][Full Text] [Related]
17. A Case of Primary Localized Small Bowel Amyloidosis Studied by 18F-Choline and Contrast-Enhanced 18F-FDG PET/CT.
Minordi LM; Caldarella C; Ripani D; Calandriello L; Manfredi R
Clin Nucl Med; 2020 Mar; 45(3):e154-e155. PubMed ID: 31977458
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET/CT in primary AL hepatic amyloidosis associated with multiple myeloma.
Son YM; Choi JY; Bak CH; Cheon M; Kim YE; Lee KH; Kim BT
Korean J Radiol; 2011; 12(5):634-7. PubMed ID: 21927567
[TBL] [Abstract][Full Text] [Related]
19. PET-CT evaluation of amyloid systemic involvement with [
Genovesi D; Vergaro G; Emdin M; Giorgetti A; Marzullo P
J Nucl Cardiol; 2017 Dec; 24(6):2025-2029. PubMed ID: 28326465
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review.
Mekinian A; Jaccard A; Soussan M; Launay D; Berthier S; Federici L; Lefèvre G; Valeyre D; Dhote R; Fain O;
Amyloid; 2012 Jun; 19(2):94-8. PubMed ID: 22587492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
